Resveratrol inhibits cell differentiation in 3T3-L1 adipocytes via activation of AMPK

Canadian Journal of Physiology and Pharmacology

Volumn 89, Issue 11, 2011, Pages 793-799

  Chen, Sifan ^a,b   Li, Zilun ^b   Li, Wenxue ^a   Shan, Zhiming ^c   Zhu, Wei ^a,b  

^a GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b SUN YAT SEN UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

3t3 l1 adipocytes; Amp activated protein kinase; Cell differentiation; Resveratrol

Indexed keywords

ADIPONECTIN; AMP ACTIVATED PROTEIN KINASE ALPHA; CCAAT ENHANCER BINDING PROTEIN ALPHA; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; LEPTIN; RESVERATROL; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; LIPOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

3T3-L1 CELLS; ADIPOCYTES; AMP-ACTIVATED PROTEIN KINASES; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CCAAT-ENHANCER-BINDING PROTEIN-ALPHA; CELL DIFFERENTIATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG EVALUATION, PRECLINICAL; LIPOGENESIS; MICE; OBESITY; PHOSPHORYLATION; PPAR GAMMA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; STILBENES;

EID: 80055077134     PISSN: 00084212     EISSN: 12057541     Source Type: Journal    
DOI: 10.1139/Y11-077     Document Type: Article

References (25)

1. Clarke, S.L., Robinson, C.E., and Gimble, J.M. 1997. CAAT/ enhancer binding proteins directly modulate transcription from the peroxisome proliferator activated receptor gamma 2 promoter. Biochem. Biophys. Res. Commun. 240(1): 99-103. doi:10.1006/ bbrc.1997.7627. PMID:9367890.
2. Fischer-Posovszky, P., Kukulus, V., Tews, D., Unterkircher, T., Debatin, K.M., Fulda, S., and Wabitsch, M. 2010. Resveratrol regulates human adipocyte number and function in a Sirt1- dependent manner. Am. J. Clin. Nutr. 92(1): 5-15. doi:10.3945/ ajcn.2009.28435. PMID:20463039.
3. Fryer, L.G., and Carling, D. 2005. AMP-activated protein kinase and the metabolic syndrome. Biochem. Soc. Trans. 33(2): 362-366. doi:10.1042/BST0330362. PMID:15787607.
4. Gonzales, A.M., and Orlando, R.A. 2007. Role of adipocyte-derived lipoprotein lipase in adipocyte hypertrophy. Nutr. Metab. 4(1): 22. doi:10.1186/1743-7075-4-22.
5. Haider, U.G., Sorescu, D., Griendling, K.K., Vollmar, A.M., and Dirsch, V.M. 2003. Resveratrol increases serine15-phosphorylated but transcriptionally impaired p53 and induces a reversible DNA replication block in serum-activated vascular smooth muscle cells. Mol. Pharmacol. 63(4): 925-932. doi:10.1124/mol.63.4.925. PMID:12644594.
6. Hsu, J.M., and Ding, S.T. 2003. Effect of polyunsaturated fatty acids on the expression of transcription factor adipocyte determination and differentiation-dependent factor 1 and of lipogenic and fatty acid oxidation enzymes in porcine differentiating adipocytes. Br. J. Nutr. 90(3): 507-513. doi:10.1079/BJN2003918. PMID:13129455.
7. Huang, B., Yuan, H.D., Kim, D.Y., Quan, H.Y., and Chung, S.H. 2011. Cinnamaldehyde prevents adipocyte differentiation and adipogenesis via regulation of peroxisome proliferator-activated receptor-gamma (PPAR gamma) and AMP-activated protein kinase (AMPK) pathways. J. Agric. Food Chem. 59(8): 3666-3673. doi:10.1021/jf104814t. PMID:21401097.
8. Kim, S.K., and Kong, C.S. 2010. Anti-adipogenic effect of dioxinodehydroeckol via AMPK activation in 3T3-L1 adipocytes. Chem. Biol. Interact. 186(1): 24-29. doi:10.1016/j.cbi.2010.04. 003. PMID:20385110.
9. Kudo, M., Sugawara, A., Uruno, A., Takeuchi, K., and Ito, S. 2004. Transcription suppression of peroxisome proliferator-activated receptor gamma2 gene expression by tumor necrosis factor alpha via an inhibition of CCAAT/enhancer-binding protein delta during the early stage of adipocyte differentiation. Endocrinology, 145 (11): 4948-4956. doi:10.1210/en.2004-0180. PMID:15284209.
10. Lehrke, M., and Lazar, M.A. 2005. The many faces of PPAR gamma. Cell, 123(6): 993-999. doi:10.1016/j.cell.2005.11.026. PMID: 16360030.
11. T method. Methods, 25(4): 402-408. doi:10.1006/meth.2001.1262. PMID:11846609.
12. Luo, Z., Saha, A.K., Xiang, X., and Ruderman, N.B. 2005. AMPK, the metabolic syndrome and cancer. Trends Pharmacol. Sci. 26(2): 69-76. doi:10.1016/j.tips.2004.12.011. PMID:15681023.
13. MacDougald, O.A., and Lane, M.D. 1995. Transcriptional regulation of gene expression during adipocyte differentiation. Annu. Rev. Biochem. 64(1): 345-373. doi:10.1146/annurev.bi.64.070195. 002021. PMID:7574486.
14. Mäuser, W., Perwitz, N., Meier, B., Fasshauer, M., and Klein, J. 2007. Direct adipotropic actions of atorvastatin: differentiation state-dependent induction of apoptosis, modulation of endocrine function, and inhibition of glucose uptake. Eur. J. Pharmacol. 564 (1-3): 37-46. doi:10.1016/j.ejphar.2007.02.024. PMID:17376428.
15. Moon, H.S., Chung, C.S., Lee, H.G., Kim, T.G., Choi, Y.J., and Cho, C.S. 2007. Inhibitory effect of (-)-epigallocatechin-3-gallate on lipid accumulation of 3T3-L1 cells. Obesity (Silver Spring), 15 (11): 2571-2582. doi:10.1038/oby.2007.309. PMID:18070748.
16. Park, H.J., Yang, J.Y., Ambati, S., Della-Fera, M.A., Hausman, D.B., Rayalam, S., and Baile, C.A. 2008. Combined effects of genistein, quercetin, and resveratrol in human and 3T3-L1 adipocytes. J. Med. Food, 11(4): 773-783. doi:10.1089/jmf.2008.0077. PMID: 19053873.
17. Picard, F., Kurtev, M., Chung, N., Topark-Ngarm, A., Senawong, T., Machado de Oliveira, R.M., et al. 2004. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature, 429(6993): 771-776. doi:10.1038/nature02583. PMID: 15175761.
18. Prusty, D., Park, B.H., Davis, K.E., and Farmer, S.R. 2002. Activation of MEK/ERK signaling promotes adipogenesis by enhancing PPARg and C/EBPa gene expression during the differentiation of 3T3-L1 pre-adipocytes. J. Biol. Chem. 277(48): 46226-46232. doi:10.1074/jbc.M207776200. PMID:12270934.
19. Ragazzi, E., Froldi, G., and Fassina, G. 1988. Resveratrol activity on guinea pig isolated trachea from normal and albumin-sensitized animals. Pharmacol. Res. Commun. 20(Suppl. 5): 79-82. doi:10. 1016/S0031-6989(88)80846-4. PMID:2907791.
20. Sozio, M.S., Liangpunsakul, S., and Crabb, D. 2010. The role of lipid metabolism in the pathogenesis of alcoholic and nonalcoholic hepatic steatosis. Semin. Liver Dis. 30(4): 378-390. doi:10.1055/ s-0030-1267538. PMID:20960377.
21. Tang, Q.Q., Otto, T.C., and Lane, M.D. 2003. CCAAT/enhancerbinding protein beta is required for mitotic clonal expansion during adipogenesis. Proc. Natl. Acad. Sci. U.S.A. 100(3): 850-855. doi:10.1073/pnas.0337434100. PMID:12525691.
22. Vázquez-Vela, M.E., Torres, N., and Tovar, A.R. 2008. White adipose tissue as endocrine organ and its role in obesity. Arch. Med. Res. 39(8): 715-728. doi:10.1016/j.arcmed.2008.09.005. PMID:18996284.
23. White, U.A., and Stephens, J.M. 2010. Transcriptional factors that promote formation of white adipose tissue. Mol. Cell. Endocrinol. 318(1-2): 10-14. doi:10.1016/j.mce.2009.08.023. PMID:19733624.
24. Wood, J.G., Rogina, B., Lavu, S., Howitz, K., Helfand, S.L., Tatar, M., and Sinclair, D. 2004. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature, 430(7000): 686-689. doi:10.1038/nature02789. PMID:15254550.
25. Yang, J.Y., Della-Fera, M.A., Rayalam, S., Ambati, S., Hartzell, D.L., Park, H.J., and Baile, C.A. 2008. Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin. Life Sci. 82(19-20): 1032-1039. doi:10.1016/j.lfs.2008.03.003. PMID:18433793.